UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy

Completed

Conditions: Colon Cancer
Lung Cancer
Breast Cancer

Interventions: Behavioral: Walk With Ease Program
Other: Collect Blood, GA and Other Survey Tools

First Posted Date: 2013-02-12

Last Posted Date: 2024-03-20

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 29

Registration Number: NCT01789983

Locations: 🇺🇸
University of North Carolina Cancer Hospital, Chapel Hill, North Carolina, United States

Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer

Completed

Conditions: Bladder Cancer

Interventions: Other: Collect Blood and Survey Instruments

First Posted Date: 2013-01-25

Last Posted Date: 2021-10-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 103

Registration Number: NCT01776138

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer

Early Phase 1

Completed

Conditions: Neoplasms
Major Depressive Disorder

Interventions: Drug: Mirtazapine
Drug: Citalopram

First Posted Date: 2012-11-12

Last Posted Date: 2017-03-13

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 21

Registration Number: NCT01725048

Locations: 🇺🇸
University of North Carolina Hospital, Chapel Hill, North Carolina, United States

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: FOLFIRINOX

First Posted Date: 2012-09-19

Last Posted Date: 2017-10-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 9

Registration Number: NCT01688336

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Metformin for the Treatment of Endometrial Hyperplasia

Early Phase 1

Completed

Conditions: Endometrial Hyperplasia Without Atypia
Endometrial Hyperplasia

Interventions: Drug: Metformin

First Posted Date: 2012-09-14

Last Posted Date: 2019-01-18

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 18

Registration Number: NCT01685762

Locations: 🇺🇸
Southern Pines Women's Health Center, Southern Pines, North Carolina, United States
🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Imaging Correlates of Renal Cell Carcinoma Biological Features

Not Applicable

Completed

Conditions: Renal Cell Carcinoma

Interventions: Procedure: FDG PET/MR

First Posted Date: 2012-08-15

Last Posted Date: 2021-01-07

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 17

Registration Number: NCT01665703

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer

Not Applicable

Completed

Conditions: Bladder Cancer

Interventions: Procedure: FDG PET/MR

First Posted Date: 2012-08-02

Last Posted Date: 2019-10-31

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 22

Registration Number: NCT01655745

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Not Applicable

Completed

Conditions: Hodgkin Lymphoma, Adult

Interventions: Drug: Brentuximab vedotin
Drug: ABVD

First Posted Date: 2012-04-17

Last Posted Date: 2021-12-07

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 41

Registration Number: NCT01578967

Locations: 🇺🇸
Rex Cancer Center, Raleigh, North Carolina, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 3 locations

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Lenalidomide

First Posted Date: 2012-04-17

Last Posted Date: 2022-01-27

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT01578954

Locations: 🇺🇸
University of North Carolina at Chapel Hill - Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)

Phase 2

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Procedure: Stereotactic Radiosurgery
Drug: Erlotinib

First Posted Date: 2012-04-09

Last Posted Date: 2021-01-12

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 32

Registration Number: NCT01573702

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
🇺🇸
University of California at San Francisco, San Francisco, California, United States
🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States

and more 5 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy